More articles from Basic and Translational Neurosciences

You have access
First-in-human brain imaging with [18F]3F4AP, a PET tracer developed for imaging demyelination
Nicolas Guehl, Yang Sun, Andrew Russo, Karla Ramos-Torres, Maeva Dhaynaut, Eric Klawiter, Georges El Fakhri, Marc Normandin and Pedro Brugarolas

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2485;
You have access
Chemistry, Radiochemistry and Preliminary Biological Evaluations of the First Brain-penetrant GPR119-based Radiotracer in Rodents and Non-human primates
Avnash Bansode, Naresh Damuka, Ivan Krizan, Nagaraju Bashetti, Mack Miller, JV Shanmukha Kumar, Suzanne Craft, Matthew Jorgensen and Kiran Solingapuram Sai

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2483;
You have access
In vivo evaluation of a novel 18F-labeled PET radioligand for translocator protein 18kDa (TSPO) in monkey brain
Xuefeng Yan, Fabrice Siméon, Jeih-San Liow, Cheryl Morse, Jose Angel Montero Santamaria, Madeline Jenkins, Lester Manly, Maia Van Buskirk, Robert Gladding, Sami Zoghbi, Victor Pike, Robert Innis and Paolo Zanotti Fregonara

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2319;
You have access
Test-retest reproducibility of FDG-PET and MRI-derived measures of brain connectivity
Aldana Lizarraga, Isabelle Ripp, Arianna Sala, Kathrin Koch and Igor Yakushev

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2427;
You have access
Cholinergic denervation is more severe in patients with Parkinson disease with premotor compared to post-motor onset REM sleep behavior disease (RBD): a 18F-FEOBV PET study
Prabesh Kanel, Yoshiaki Ota and Nicolaas Bohnen

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2310;
You have access
Quantitative biodistribution of class-IIa histone deacetylases in rat brain with novel PET tracers
Nashaat Turkman

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2321;
You have access
[18F] SynVesT-1 PET Imaging on Levetiracetam Efficacy Evaluation of Epileptic Rats
Shijun Xiang, Yongxiang Tang, Zehua Zhu, Bei Chen, Haoyue Zhu, Ling Xiao, Wanqian Rao, Jinhui Yang and Shuo Hu

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2312;
You have access
First-in-human evaluation of 18F-PF-06445974, a PET radioligand that preferentially labels phosphodiesterase-4B
Yuichi Wakabayashi, Per Stenkrona, Ryosuke Arakawa, Xuefeng Yan, Maia Van Buskirk, Madeline Jenkins, Jose Angel Montero Santamaria, Kevin Maresca, Akihiro Takano, Jeih-San Liow, Thomas Chappie, Andrea Varrone, Sangram Nag, Lei Zhang, Zoe Hughes, Christopher Schmidt, Shawn Doran, Andrew Mannes, Paolo Zanotti Fregonara, Maarten Ooms, Cheryl Morse, Sami Zoghbi, Christer Halldin, Victor Pike and Robert Innis

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2482;
You have access
In vivo dissociation rates of 2-[18F]F-A85380 and [18F]Nifene measured with PET imaging identify mechanisms of nicotine addiction and smoking cessation.
Matthew Zammit, Chien-Min Kao, Hannah Zhang, Nathanial Holderman, Hsiu-Ming Tsai, Anitha Govind, Samuel Mitchell, Mohammed Bhuiyan, Richard Freifelder, Jogeshwar Mukherjee, William Green and Chin-Tu Chen

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2316;
You have access
Synthesis and initial in vivo evaluation of F-18 radioligands for S1PR1 PET imaging
Lin Qiu, Hao Jiang, Jinzhi Wang, Yanbo Yu, Haiyang Zhao, Tianyu Huang, Joel Perlmutter, Robert J. Gropler and Zhude Tu

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2320;

Main menu

User menu

Search

More articles from Basic and Translational Neurosciences

Pages